Integrated Network Pharmacology, ADMET Profiling, and Molecular Docking Investigation of Losartan and Its Active Metabolite Against Angiotensin-Related Target. (2026). International Journal of Pharmaceutical Research and Medicinal Plants, 2(5), 76-82. https://doi.org/10.61280/4sa10p81